1. WANBURY LIMITED
stock logo

WANBURY LIMITED Share Price

WANBURY

₹161.70+₹3.75 (2.37%) Past YearLast updated on 24 Apr, 2024 | 03:47 PM IST
₹159.15₹163.10
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

What’s in news?

arrow
Empty state

No data available at the moment

Company overview

About

arrow

Market cap

Market Cap Switch₹517 Cr

Open

₹159.80

Close

₹157.95

Circuit range

₹165.80 - ₹150.05

Day range

₹159.15 - ₹163.10

Year range

₹39.40 - ₹179.35

Volume

76,871

Avg. traded

₹161.48

Revenue (12m)

₹569 Cr

WANBURY LIMITEDWanbury Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical and related activities, including research. The Company operates through two divisions: the Active Pharmaceutical Ingredients (API) Business and the Domestic Formulations Business. The Company, through the Active Pharmaceutical Ingredients (API) Business, provides Metformin and Sertraline. Metformin is used for the treatment for type 2 diabetes and Sertraline is an anti-depressant. It has approximately 13 API products. It manufactures Metformin with over 8500 tons per year. Its products include Metformin HCL, Metformin DC/SR, Sertraline, Diphenhydramine, Mefenamic Acid, Glucosamine, Methoxsalen and Paroxetine. The Company's subsidiaries include Wanbury Holdings B. V. (Netherland), Wanbury Global FZE (UAE), Ningxia Wanbury Fine Chemicals Co. Ltd. (China) and Cantabria Pharma S. L. (Spain).

Read more

WANBURY LIMITED Key indicators

arrow

52 week high

₹179.35

52 week low

₹39.40

P/E ratio

22.18

P/B ratio

-43.48

ROE

--

ROCE

17.68%

Dividend yield

--

Debt/Equity ratio

-7.12

EPS

-3.18

Learn more

Investment checklist: (1/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

4.73%

Net profit margin

-2.04%

ROE

0%

ROA

-3.24%

ROCE

17.68%

Learn more

WANBURY LIMITED Shareholder returns

arrow

1 day

-1.03%

1 week

+5.16%

1 month

+12.50%

3 months

+8.15%

1 year

+295.37%

3 years

+66.53%

5 years

+626.21%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

WANBURY LIMITED Share Price history

arrow
DayOpenCloseDay’s change
Tue, Apr 23 2024
₹161.50
₹157.95
-2.25%
Mon, Apr 22 2024
₹152.50
₹159.60
+4.45%
Fri, Apr 19 2024
₹148.20
₹152.00
+2.50%
Thu, Apr 18 2024
₹149.20
₹148.25
-0.64%
Tue, Apr 16 2024
₹150.00
₹150.80
+0.53%
Mon, Apr 15 2024
₹151.65
₹150.20
-0.97%
Fri, Apr 12 2024
₹161.40
₹153.65
-5.04%
Wed, Apr 10 2024
₹160.90
₹159.65
-0.78%

Shareholding info

arrow

Promoters (39.79%)

Mutual Funds (0%)

Retail and other (60.03%)

Foreign institutions-FII (0.18%)

Other domestic institutions (0%)

Retail and other

Learn more

Events

Empty state

No data available at the moment

Frequently asked questions